$ALXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALEXION PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALEXION PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 18 19 20 21 22
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 1,875 | 4,453 | 30,001 | 28.1 K to 30 K (+6.67 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 3,125 | 7,422 | 13,125 | |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 1,875 | 4,453 | 0 | |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 21.00 | 1,000 | 21,001 | 28,126 | 29.1 K to 28.1 K (-3.43 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.82 | 336 | 6,996 | 29,126 | 29.5 K to 29.1 K (-1.14 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.84 | 1,964 | 40,930 | 29,462 | 31.4 K to 29.5 K (-6.25 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 21.17 | 1,700 | 35,989 | 31,426 | 33.1 K to 31.4 K (-5.13 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 3,125 | 7,422 | 33,126 | 30 K to 33.1 K (+10.42 %) |
Nov 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 1,875 | 4,453 | 30,001 | 28.1 K to 30 K (+6.67 %) |
Nov 15 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Gift | G | 0.00 | 1,200 | 0 | 28,126 | 29.3 K to 28.1 K (-4.09 %) |
Nov 15 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Gift | G | 0.00 | 1,200 | 0 | 29,326 | 30.5 K to 29.3 K (-3.93 %) |
Nov 15 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Gift | G | 0.00 | 1,200 | 0 | 30,526 | 31.7 K to 30.5 K (-3.78 %) |
Nov 09 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 1,501 | 3,565 | 67,708 | |
Nov 09 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 11,952 | 28,386 | 0 | |
Nov 09 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 19.94 | 7,801 | 155,552 | 255,312 | 263.1 K to 255.3 K (-2.96 %) |
Nov 09 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 1,501 | 3,565 | 263,113 | 261.6 K to 263.1 K (+0.57 %) |
Nov 09 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 11,952 | 28,386 | 261,612 | 249.7 K to 261.6 K (+4.79 %) |
Nov 08 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 547 | 1,299 | 11,952 | |
Nov 08 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.00 | 199 | 3,980 | 249,660 | 249.9 K to 249.7 K (-0.08 %) |
Nov 08 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 547 | 1,299 | 249,859 | 249.3 K to 249.9 K (+0.22 %) |
Nov 01 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | M | 2.38 | 11,500 | 27,313 | 2,000 | |
Nov 01 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 17.90 | 6,000 | 107,400 | 44,500 | 50.5 K to 44.5 K (-11.88 %) |
Nov 01 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Buy | M | 2.38 | 11,500 | 27,313 | 50,500 | 39 K to 50.5 K (+29.49 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 29,167 | 69,272 | 12,499 | |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.85 | 2,527 | 42,580 | 249,312 | 251.8 K to 249.3 K (-1.00 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.90 | 923 | 15,599 | 251,839 | 252.8 K to 251.8 K (-0.37 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.91 | 571 | 9,656 | 252,762 | 253.3 K to 252.8 K (-0.23 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.95 | 4,375 | 74,156 | 253,333 | 257.7 K to 253.3 K (-1.70 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.96 | 200 | 3,392 | 257,708 | 257.9 K to 257.7 K (-0.08 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.97 | 100 | 1,697 | 257,908 | 258 K to 257.9 K (-0.04 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.00 | 5,279 | 89,743 | 258,008 | 263.3 K to 258 K (-2.01 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.03 | 325 | 5,535 | 263,287 | 263.6 K to 263.3 K (-0.12 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.05 | 100 | 1,705 | 263,612 | 263.7 K to 263.6 K (-0.04 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.07 | 1,000 | 17,070 | 263,712 | 264.7 K to 263.7 K (-0.38 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.08 | 300 | 5,124 | 264,712 | 265 K to 264.7 K (-0.11 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.20 | 500 | 8,600 | 265,012 | 265.5 K to 265 K (-0.19 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.21 | 100 | 1,721 | 265,512 | 265.6 K to 265.5 K (-0.04 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.30 | 700 | 12,110 | 265,612 | 266.3 K to 265.6 K (-0.26 %) |
Oct 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 29,167 | 69,272 | 266,312 | 237.1 K to 266.3 K (+12.30 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 18,125 | 43,047 | 1,875 | |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.11 | 2,725 | 46,625 | 31,726 | 34.5 K to 31.7 K (-7.91 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.50 | 400 | 7,000 | 34,451 | 34.9 K to 34.5 K (-1.15 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.30 | 5,000 | 86,500 | 34,851 | 39.9 K to 34.9 K (-12.55 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.26 | 4,600 | 79,396 | 39,851 | 44.5 K to 39.9 K (-10.35 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 17.30 | 400 | 6,920 | 44,451 | 44.9 K to 44.5 K (-0.89 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 16.70 | 110 | 1,837 | 44,851 | 45 K to 44.9 K (-0.24 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 16.65 | 4,890 | 81,419 | 44,961 | 49.9 K to 45 K (-9.81 %) |
Oct 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 18,125 | 43,047 | 49,851 | 31.7 K to 49.9 K (+57.13 %) |
Oct 15 2004 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP Finance & Admini ... | Option Exercise | M | 2.38 | 10,000 | 23,750 | 0 | |
Oct 15 2004 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP Finance & Admini ... | Buy | M | 2.38 | 10,000 | 23,750 | 23,300 | 13.3 K to 23.3 K (+75.19 %) |
Oct 15 2004 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | VP & General Counse ... | Buy | P | 17.34 | 949 | 16,456 | 2,000 | 1.1 K to 2 K (+90.29 %) |
Oct 15 2004 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | VP & General Counse ... | Buy | P | 17.31 | 100 | 1,731 | 1,051 | 951 to 1.1 K (+10.52 %) |
Oct 15 2004 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | VP & General Counse ... | Buy | P | 17.30 | 300 | 5,190 | 951 | 651 to 951 (+46.08 %) |
Oct 15 2004 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | VP & General Counse ... | Buy | P | 17.29 | 651 | 11,256 | 651 | 0 to 651 |
Sep 27 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 8,334 | 19,793 | 41,666 | |
Sep 27 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 20,833 | 49,478 | 0 | |
Sep 27 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.90 | 2,167 | 38,789 | 237,145 | 239.3 K to 237.1 K (-0.91 %) |
Sep 27 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.45 | 5,000 | 87,250 | 239,312 | 244.3 K to 239.3 K (-2.05 %) |
Sep 27 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 17.55 | 2,000 | 35,100 | 244,312 | 246.3 K to 244.3 K (-0.81 %) |
Sep 27 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 8,334 | 19,793 | 246,312 | 238 K to 246.3 K (+3.50 %) |
Sep 27 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 20,833 | 49,478 | 237,978 | 217.1 K to 238 K (+9.59 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Option Exercise | M | 2.38 | 1,250 | 2,969 | 3,750 | |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Option Exercise | M | 2.38 | 6,875 | 16,328 | 0 | |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Option Exercise | M | 2.38 | 10,000 | 23,750 | 20,000 | |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Buy | M | 2.38 | 1,250 | 2,969 | 31,726 | 30.5 K to 31.7 K (+4.10 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Buy | M | 2.38 | 6,875 | 16,328 | 30,476 | 23.6 K to 30.5 K (+29.13 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Sell | S | 17.50 | 5,000 | 87,500 | 23,601 | 28.6 K to 23.6 K (-17.48 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Sell | S | 17.75 | 5,000 | 88,750 | 28,601 | 33.6 K to 28.6 K (-14.88 %) |
Sep 16 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Buy | M | 2.38 | 10,000 | 23,750 | 33,601 | 23.6 K to 33.6 K (+42.37 %) |
Sep 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | M | 2.38 | 11,500 | 27,313 | 2,000 | |
Sep 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 18.05 | 200 | 3,610 | 39,000 | 39.2 K to 39 K (-0.51 %) |
Sep 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 18.06 | 3,800 | 68,628 | 39,200 | 43 K to 39.2 K (-8.84 %) |
Sep 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Buy | M | 2.38 | 11,500 | 27,313 | 43,000 | 31.5 K to 43 K (+36.51 %) |
Aug 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 29,167 | 69,272 | 20,833 | |
Aug 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 15.55 | 3,480 | 54,114 | 217,145 | 220.6 K to 217.1 K (-1.58 %) |
Aug 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.00 | 996 | 15,936 | 220,625 | 221.6 K to 220.6 K (-0.45 %) |
Aug 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.40 | 300 | 4,920 | 221,621 | 221.9 K to 221.6 K (-0.14 %) |
Aug 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 16.41 | 224 | 3,676 | 221,921 | 222.1 K to 221.9 K (-0.10 %) |
Aug 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 15.70 | 4,167 | 65,422 | 222,145 | 226.3 K to 222.1 K (-1.84 %) |
Aug 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 29,167 | 69,272 | 226,312 | 197.1 K to 226.3 K (+14.79 %) |
Aug 31 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | M | 2.38 | 11,500 | 27,313 | 13,500 | |
Aug 31 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 16.10 | 4,000 | 64,400 | 31,500 | 35.5 K to 31.5 K (-11.27 %) |
Aug 31 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Buy | M | 2.38 | 11,500 | 27,313 | 35,500 | 24 K to 35.5 K (+47.92 %) |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Option Exercise | M | 2.38 | 8,125 | 19,297 | 24,375 | |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Option Exercise | M | 2.38 | 10,000 | 23,750 | 30,000 | |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Buy | M | 2.38 | 8,125 | 19,297 | 23,601 | 15.5 K to 23.6 K (+52.50 %) |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Sell | S | 15.30 | 10,000 | 153,000 | 15,476 | 25.5 K to 15.5 K (-39.25 %) |
Aug 18 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP& Head ... | Buy | M | 2.38 | 10,000 | 23,750 | 25,476 | 15.5 K to 25.5 K (+64.62 %) |
Aug 13 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | D | 10.74 | 1,334 | 14,327 | 2,666 | |
Aug 13 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | D | 15.58 | 2,500 | 38,950 | 5,000 | |
Aug 13 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | D | 21.76 | 5,000 | 108,800 | 2,500 | |
Aug 13 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | D | 11.75 | 667 | 7,837 | 0 | |
Aug 13 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 10.74 | 1,334 | 14,327 | 37,667 | 36.3 K to 37.7 K (+3.67 %) |
Aug 13 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 15.58 | 2,500 | 38,950 | 36,333 | 33.8 K to 36.3 K (+7.39 %) |
Aug 13 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 21.76 | 5,000 | 108,800 | 33,833 | 28.8 K to 33.8 K (+17.34 %) |
Aug 13 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 11.75 | 667 | 7,837 | 28,833 | 28.2 K to 28.8 K (+2.37 %) |
Jul 19 2004 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Senior Vice Preside ... | Sell | S | 16.61 | 700 | 11,627 | 35,196 | 35.9 K to 35.2 K (-1.95 %) |
Jul 19 2004 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Senior Vice Preside ... | Sell | S | 16.64 | 1,300 | 21,632 | 35,896 | 37.2 K to 35.9 K (-3.49 %) |
Jun 17 2004 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | P | 18.14 | 1,000 | 18,140 | 1,000 | 0 to 1,000 |
Jun 17 2004 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Buy | P | 18.14 | 1,000 | 18,140 | 1,000 | 0 to 1,000 |
May 11 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 21.01 | 4,000 | 84,040 | 200,145 | 204.1 K to 200.1 K (-1.96 %) |
May 11 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP/Head o ... | Sell | S | 21.01 | 5,000 | 105,050 | 15,476 | 20.5 K to 15.5 K (-24.42 %) |
Apr 20 2004 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP Finance & Admins ... | Sell | S | 23.41 | 5,000 | 117,050 | 13,300 | 18.3 K to 13.3 K (-27.32 %) |
May 11 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 21.01 | 3,000 | 63,030 | 24,000 | 27 K to 24 K (-11.11 %) |
Apr 20 2004 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Sr. Vice President | Sell | S | 23.27 | 4,300 | 100,061 | 37,196 | 41.5 K to 37.2 K (-10.36 %) |
Mar 02 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 25.00 | 6,000 | 150,000 | 204,145 | 210.1 K to 204.1 K (-2.86 %) |
Feb 26 2004 | ALXN | ALEXION PHARMACEUT ... | MOTOLA NANCY | Sr. VP Regulatory & ... | Option Exercise | A | 23.29 | 10,000 | 232,900 | 10,000 | |
Feb 26 2004 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP Finance & Admini ... | Option Exercise | A | 23.29 | 10,000 | 232,900 | 10,000 | |
Feb 26 2004 | ALXN | ALEXION PHARMACEUT ... | ROLLINS SCOTT A | SR. VP Drug Dev & P ... | Option Exercise | A | 23.29 | 10,000 | 232,900 | 10,000 | |
Feb 26 2004 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Senior Vice Preside ... | Option Exercise | A | 23.29 | 10,000 | 232,900 | 10,000 | |
Feb 25 2004 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | Sr. VP Clinical Dev ... | Option Exercise | A | 23.29 | 15,000 | 349,350 | 15,000 | |
Feb 25 2004 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | Vice President & Ge ... | Option Exercise | A | 23.29 | 10,000 | 232,900 | 10,000 | |
Feb 25 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP & Head of R ... | Option Exercise | A | 23.29 | 10,000 | 232,900 | 10,000 | |
Feb 25 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | A | 23.29 | 10,000 | 232,900 | 10,000 | |
Feb 25 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | A | 23.29 | 17,000 | 395,930 | 17,000 | |
Feb 10 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP/Head o ... | Sell | S | 20.58 | 5,000 | 102,875 | 20,476 | 25.5 K to 20.5 K (-19.63 %) |
Feb 10 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 20.58 | 3,000 | 61,725 | 27,000 | 30 K to 27 K (-10.00 %) |
Feb 10 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.58 | 4,000 | 82,300 | 210,145 | 214.1 K to 210.1 K (-1.87 %) |
Feb 09 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec VP, Head of Re ... | Buy | J | 17.35 | 399 | 6,923 | 25,476 | 25.1 K to 25.5 K (+1.59 %) |
Dec 17 2003 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | A | 17.05 | 7,500 | 127,875 | 7,500 | |
Dec 17 2003 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 17.05 | 7,500 | 127,875 | 7,500 | |
Dec 17 2003 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 17.05 | 7,500 | 127,875 | 7,500 | |
Dec 17 2003 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Option Exercise | A | 17.05 | 7,500 | 127,875 | 7,500 | |
Dec 17 2003 | ALXN | ALEXION PHARMACEUT ... | JACKSON JERRY T | Director | Option Exercise | A | 17.05 | 7,500 | 127,875 | 7,500 | |
Dec 03 2003 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.20 | 4,000 | 80,800 | 214,145 | 218.1 K to 214.1 K (-1.83 %) |
Dec 03 2003 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP/Head o ... | Sell | S | 20.20 | 5,000 | 101,000 | 25,077 | 30.1 K to 25.1 K (-16.62 %) |
Dec 03 2003 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President, Chief Op ... | Sell | S | 20.20 | 3,000 | 60,600 | 30,000 | 33 K to 30 K (-9.09 %) |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Exec. VP & Head of ... | Option Exercise | A | 17.67 | 12,000 | 212,040 | 12,000 | |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | ROLLINS SCOTT A | Sr. VP Drug Dev. & ... | Option Exercise | A | 17.67 | 10,000 | 176,700 | 10,000 | |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | MOTOLA NANCY | VP Regulatory & Qua ... | Option Exercise | A | 17.67 | 10,000 | 176,700 | 10,000 | |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | VP Clinical Develop ... | Option Exercise | A | 17.67 | 10,000 | 176,700 | 10,000 | |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | Vice Pres., Finance ... | Option Exercise | A | 17.67 | 10,000 | 176,700 | 10,000 | |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | A | 17.67 | 12,000 | 212,040 | 12,000 | |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Senior Vice Preside ... | Option Exercise | A | 17.67 | 10,000 | 176,700 | 10,000 | |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | Vice Pres. & Genera ... | Option Exercise | A | 17.67 | 10,000 | 176,700 | 10,000 | |
Nov 13 2003 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | A | 17.67 | 20,000 | 353,400 | 20,000 | |
Oct 03 2003 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | Executive VP | Sell | S | 20.01 | 5,000 | 100,050 | 30,077 | 35.1 K to 30.1 K (-14.25 %) |
Oct 03 2003 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President, Chief Op ... | Sell | S | 20.01 | 3,000 | 60,030 | 33,000 | 36 K to 33 K (-8.33 %) |
Oct 03 2003 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.01 | 4,000 | 80,040 | 215,145 | 219.1 K to 215.1 K (-1.83 %) |